Noninvasive assessment of Crohn's disease activity: A comparison of 18F-fluorodeoxyglucose positron emission tomography, hydromagnetic resonance imaging, and granulocyte scintigraphy with labeled antibodies

American Journal of Gastroenterology

Volumn 97, Issue 8, 2002, Pages 1978-1985

  Neurath, M F ^a   Vehling, D ^a   Schunk, K ^a   Holtmann, M ^a   Brockmann, H ^a   Helisch, A ^a   Orth, T ^a   Schreckenberger, M ^a   Galle, P R ^a   Bartenstein, P ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GRANULOCYTE ANTIBODY;

ADULT; ANTIBODY LABELING; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; ENTERITIS; FEMALE; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; ILEUM; INTERMETHOD COMPARISON; IRRITABLE COLON; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INVASIVE MEASUREMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SENSITIVITY ANALYSIS; STANDARDIZATION; STATISTICAL ANALYSIS;

ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; COLONOSCOPY; CROHN DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; GRANULOCYTES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MEMBRANE GLYCOPROTEINS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036678049     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04192-8     Document Type: Article

References (30)

1. Inflammatory bowel disease
2. Immunological diseases of the gastrointestinal tract
3. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease
4. Postoperative recurrence of Crohn's disease: The enemy is within the fecal stream
5. Reciprocal IFN-gamma and TGF-beta responses regulate the occurrence of mucosal inflammation
6. Blockade of IL-6 transsignaling suppresses T cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn's disease and experimental colitis in vivo
7. Regulation of T-cell apoptosis in inflammatory bowel disease: To die or not to die, that is the mucosal question
8. Imaging of inflammatory bowel diseases
9. Assessment of inflammatory activity in Crohn disease with hydro-MRI
10. Crohn's disease
11. Crohn's disease
12. Focal white-matter lesions in brain of patients with inflammatory bowel disease
13. Crohn's disease: Pilot study comparing MRI of the abdomen with clinical evaluation
14. Crohn's disease evaluation: Comparison of contrast-enhanced MR imaging and single-phase helical CT scanning
15. Hydro-MRI in Crohn's disease: Appraisal of disease activity
16. Central motor processing in Huntington's disease. A PET study
17. F-18 FDG uptake in breast infection and inflammation
18. The role of positron emission tomography in oncology and other whole-body applications
19. Exclusion of chronic osteomyelitis with F-18 fluorodeoxyglucose positron emission tomographic imaging
20. Inflammatory bowel disease activity measured by positron-emission tomography
21. European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment
22. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
23. Immunoscintigraphy of an inflammatory process in Crohn's disease with a technetium-99m-labeled fragment (MN3 Fab′) and with an intact monoclonal anti-granulocyte antibody (Mab BW 250/183)
24. Current imaging in Crohn's disease: Value of MRI compared with conventional proceedings
25. The hydro-MRT of chronic inflammatory bowel diseases
26. Follow-up of Crohn's disease: Can hydro-MRI replace fractionated gastrointestinal passage examination?
27. Magnetic resonance imaging in inflammatory bowel disease
28. Breath-hold fast spin-echo MR imaging of Crohn's disease
29. MR imaging of the small bowel using the HASTE sequence
30. 18F-Fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease